Intestinal Neuroendocrine Carcinoma
2 clinical trials · Condition
◉ Watch Intestinal Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas (NCT02595424) | ECOG-ACRIN Cancer Research Group | 2015-11-06 |
Track Intestinal Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.